UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.

Iota Biosciences, a US-based medical device manufacturer spun out of University of California (UC) Berkeley, has closed a $15m series A round backed by investors including pharmaceutical firm Astellas. Horizons Ventures, Bold Capital Partners, Ironfire and Shanda also supplied capital. The round closed in May 2018, but details were only revealed last week. Founded in…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.